Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May 23;10(3):429-36.
doi: 10.5009/gnl15021.

Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response

Affiliations

Predicting Liver-Related Events Using Transient Elastography in Chronic Hepatitis C Patients with Sustained Virological Response

Hye Won Lee et al. Gut Liver. .

Erratum in

Abstract

Background/aims: Few studies have investigated prognostic factors for the development of liver-related events (LREs) in patients with chronic hepatitis C (CHC) who achieve sustained virological response (SVR).

Methods: We analyzed 190 patients with CHC who achieved SVR after treatment with pegylated interferon (peg-IFN) plus ribavirin. LREs were defined as any complications related to cirrhosis, hepatocellular carcinoma (HCC), or liver-related mortality.

Results: The mean age was 54.1 years, and 84 of the patients (44.2%) were male. The mean liver stiffness (LS) value at SVR was 7.1±5.4 kPa. During the follow-up period (median, 43.0 months), LREs occurred in 10 patients (5.3%; HCC in eight patients, ascites in one patient, and liver-related mortality in one patient). By multivariate Cox regression analysis, age, α-fetoprotein level, and LS value were independent predictors for LRE development (all p<0.05). Patients with LS values ≥7.0 kPa had a greater risk (hazard ratio, 9.472; 95% confidence interval, 1.018 to 88.126; p=0.048) for LRE development compared to those with LS values <7.0 kPa.

Conclusions: The LS value at SVR is useful for predicting LRE development in CHC patients who achieve SVR after treatment with peg-IFN plus ribavirin. Thus, LRE surveillance strategies might be optimized according to the LS values at SVR, even with complete viral eradication.

Keywords: Carcinoma, hepatocellular; Hepatitis C, chronic; Liver stiffness; Sustained virological response; Transient elastography.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Recruitment algorithm. A total of 256 patients with chronic hepatitis C (CHC) who were treated with pegylated interferon (peg-IFN) and ribavirin were enrolled. Of these, 66 patients were excluded based on our exclusion criteria. A final total of 190 patients were selected for statistical analysis. HIV, human immunodeficiency virus; HCC, hepatocellular carcinoma; LS, liver stiffness; SVR, sustained virological response.
Fig. 2
Fig. 2
Cumulative incidence rates of liver-related event (LRE) development. The cumulative incidence rates of LRE development at 1, 2, and 3 years were 0.5%, 1.1%, and 2.1%, respectively. AFP, α-fetoprotein.
Fig. 3
Fig. 3
Cumulative incidence rates of liver-related event (LRE) development based on stratified age and liver stiffness values. The cumulative incidence rates of LRE development increased significantly in older patients (A), those with higher α-fetoprotein (AFP) levels (B), and those with higher liver stiffness (LS) values at sustained virological response (C) (log-rank test, all p<0.05).

Similar articles

Cited by

References

    1. Morisco F, Granata R, Stroffolini T, et al. Sustained virological response: a milestone in the treatment of chronic hepatitis C. World J Gastroenterol. 2013;19:2793–2798. doi: 10.3748/wjg.v19.i18.2793. - DOI - PMC - PubMed
    1. Bruno S, Crosignani A, Facciotto C, et al. Sustained virologic response prevents the development of esophageal varices in compensated, Child-Pugh class A hepatitis C virus-induced cirrhosis: a 12-year prospective follow-up study. Hepatology. 2010;51:2069–2076. doi: 10.1002/hep.23528. - DOI - PubMed
    1. Fernández-Rodríguez CM, Alonso S, Martinez SM, et al. Peginterferon plus ribavirin and sustained virological response in HCV-related cirrhosis: outcomes and factors predicting response. Am J Gastroenterol. 2010;105:2164–2172. doi: 10.1038/ajg.2010.294. - DOI - PubMed
    1. Bruno S, Stroffolini T, Colombo M, et al. Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. Hepatology. 2007;45:579–587. doi: 10.1002/hep.21492. - DOI - PubMed
    1. Aleman S, Rahbin N, Weiland O, et al. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis. Clin Infect Dis. 2013;57:230–236. doi: 10.1093/cid/cit234. - DOI - PubMed

LinkOut - more resources